For medical and dental instruments UP is becoming an emerging manufacturing center. On the release of a study titled “Indian Medical Devices Industry: The way ahead” D.S. Rawat, national secretary general of Assocham said “By 2020, UP could emerge as manufacturing hub if tax concessions are made available for the medical device industry in the state. Currently 33 factories operates in UP which 10 % of the overall factories in the country and ranks second. Gujarat ranks first with 18% share. UP also ranks second in terms of employment in medical and dental fields. READ ALSO: Dental Market in India, How to get Manufacturing License in India.

The imports of medical products in India is also expected to grow (How to register your medical devices in India) as a result of surging middle class, aging population, increase in medical tourism, investment in private sector and governments commitment to drive healthcare services to rural areas, the study stated. READ ALSO: Statistics and Figures: Medical Devices, Why should you invest in India.

Yahoo News

Other News

  • Medical Devices

India Medical Device Pricing Strategy: Ensuring Growth & Affordability

India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]

Read More

Imports of High-Value Medical Equipment

High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]

Read More

SEC Committee: Pioneering Medical Approvals

New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]

Read More
  • ErlySign's Oral Cancer Detection

ErlySign Oral Cancer Detection Technology Gets CDSCO Nod

ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]

Read More

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More